Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

702 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT.
Wang JJ, van der Neut Kolfschoten M, Rutten L, Armour B, Tan CW, Chataway T, Bos R, Koornneef A, Abeywickrema P, Kapur R, Porcelijn L, Khalifa M, Sadi A, Bouchier P, Kourkouta E, Perkasa A, Kwaks T, Zahn R, Solforosi L, Gordon TP. Wang JJ, et al. Among authors: bos r. Blood. 2024 Jan 25;143(4):370-374. doi: 10.1182/blood.2023021307. Blood. 2024. PMID: 37976451 No abstract available.
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2.
Swart M, van der Lubbe J, Schmit-Tillemans S, van Huizen E, Verspuij J, Gil AI, Choi Y, Daal C, Perkasa A, de Wilde A, Claassen E, de Jong R, Wiese KE, Cornelissen L, van Es M, van Heerden M, Kourkouta E, Tahiri I, Mulders M, Vreugdenhil J, Feddes-de Boer K, Muchene L, Tolboom J, Dekking L, Juraszek J, Vellinga J, Custers J, Bos R, Schuitemaker H, Wegmann F, Roozendaal R, Kuipers H, Zahn R. Swart M, et al. Among authors: bos r. NPJ Vaccines. 2023 Mar 16;8(1):40. doi: 10.1038/s41541-023-00633-x. NPJ Vaccines. 2023. PMID: 36927774 Free PMC article.
Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine.
van der Neut Kolfschoten M, Inganäs H, Perez-Peinado C, Calado da Silva Freire J, Melchers JM, van Dijk N, Przeradzka M, Kourkouta E, van Manen D, Vellinga J, Custers J, Bos R. van der Neut Kolfschoten M, et al. Among authors: bos r. J Thromb Haemost. 2024 Apr;22(4):1046-1055. doi: 10.1016/j.jtha.2023.12.020. Epub 2023 Dec 29. J Thromb Haemost. 2024. PMID: 38159648 Free article.
Growth and gut comfort of healthy term infants exclusively fed with a partially hydrolysed protein-based infant formula: a randomized controlled double-blind trial.
Kantaras P, Kokkinopoulou A, Hageman JHJ, Hassapidou M, Androutsos O, Kanaki M, Bovee-Oudenhoven I, Karaglani E, Kontochristopoulou AM, Bos R, Manios Y. Kantaras P, et al. Among authors: bos r. Front Pediatr. 2024 May 17;12:1328709. doi: 10.3389/fped.2024.1328709. eCollection 2024. Front Pediatr. 2024. PMID: 38827219 Free PMC article.
PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs.
van de Laar CJ, Oude Voshaar MAH, Ten Klooster P, Tedjo DI, Bos R, Jansen T, Willemze A, Versteeg GA, Goekoop-Ruiterman YPM, Kroot EJ, van de Laar M. van de Laar CJ, et al. Among authors: bos r. RMD Open. 2024 May 30;10(2):e004291. doi: 10.1136/rmdopen-2024-004291. RMD Open. 2024. PMID: 38816210 Free article. Clinical Trial.
Development and External Validation of a Prediction Model for Patients with Varicose Veins Suitable for Isolated Ambulatory Phlebectomy.
Scheerders ERY, van Klaveren D, Malskat WSJ, van Rijn MJE, van der Velden SK, Nijsten T, van den Bos RR. Scheerders ERY, et al. Among authors: van den bos rr. Eur J Vasc Endovasc Surg. 2024 May 4:S1078-5884(24)00378-2. doi: 10.1016/j.ejvs.2024.05.001. Online ahead of print. Eur J Vasc Endovasc Surg. 2024. PMID: 38710320 Free article.
702 results